FBI Probes Jim Irsay Death Over Prescription Drugs, Ketamine Use and Doctor Relationship: Report

FBI Investigation into Jim Irsay’s Death and Prescription Drug Use

Federal authorities have initiated an investigation into the death of Jim Irsay, the longtime owner of the Indianapolis Colts, scrutinizing his use of prescription medications and ketamine treatments. Central to the inquiry is the involvement of Dr. Harry Haroutunian, a California-based addiction specialist who treated Irsay in the months leading up to his passing. According to reports, the FBI issued a federal grand jury subpoena earlier this month, seeking documents related to Irsay’s medical history, drug use, and his relationship with Dr. Haroutunian.

The investigation also included several days of activity in Indianapolis, where officials gathered additional information. The FBI has declined to provide comments on the matter, maintaining confidentiality as the probe continues. Meanwhile, Colts Chief Legal Officer Dan Emerson confirmed awareness of subpoenas but clarified that neither he nor the Colts organization had been directly served or involved in the investigation at this time.

Background on Jim Irsay’s Health and Medical Treatment

Jim Irsay, who took ownership of the Colts in 1997, passed away in May at the age of 65. His death certificate, signed by Dr. Haroutunian, lists cardiac arrest caused by acute pneumonia as the primary cause, with two heart conditions noted as contributing factors. Notably, no official autopsy was performed following his death.

Throughout his life, Irsay faced numerous health challenges, including battles with drug and alcohol addiction. He openly admitted to attending rehab facilities at least 15 times. In January 2024, the Colts announced that Irsay was undergoing treatment for a severe respiratory illness. By February, he shared on social media that he was “on the mend,” signaling some recovery progress.

In December 2023, police responded to a call at Irsay’s home early in the morning, discovering him unresponsive in bed. Authorities described the incident as a “suspected overdose.” However, Irsay later disputed this characterization, emphasizing that it was not an overdose and expressing frustration over the public speculation given his past struggles.

Reports indicate that Dr. Haroutunian prescribed Irsay over 200 opioid pills prior to the December incident. Additionally, ketamine treatments were administered during a period when Irsay was reportedly experiencing a relapse. These treatments occurred at both his Indianapolis residence and a rental property in Miami.

The Role of Dr. Harry Haroutunian in the Investigation

Dr. Harry Haroutunian, an addiction specialist based in California, has come under scrutiny as part of the FBI’s probe. His involvement with Irsay’s care, including the prescription of opioids and ketamine, is a focal point of the investigation. The doctor signed Irsay’s death certificate, attributing the cause of death to cardiac arrest linked to pneumonia, but questions remain about the extent and appropriateness of the treatments provided.

The Colts organization has issued a statement acknowledging awareness of the ongoing investigation but emphasized that they have not been contacted by the FBI or served with subpoenas. The team is cooperating with authorities as necessary but maintains that the inquiry has not directly implicated the franchise or its current employees.

Jim Irsay’s History with Substance Abuse and Legal Issues

Jim Irsay’s struggles with substance abuse have been well-documented over the years. In 2014, he was arrested and pleaded guilty to operating while intoxicated (OWI). This incident resulted in a six-game suspension from the NFL and a $500,000 fine. Irsay has reflected on the arrest, attributing some of the public and legal response to his status as a White billionaire.

His family’s connection to the Colts dates back to 1972 when his father purchased the team for $12 million while it was still based in Baltimore. The franchise relocated to Indianapolis in 1984. Irsay served as the team’s general manager from 1982 until 1996 and became the youngest NFL owner at age 37 after his father’s death in 1997.

Under Irsay’s leadership, the Colts achieved significant success, winning 258 games—the fourth-most in the NFL during that period. The team secured 10 division titles, made 18 playoff appearances, and reached the Super Bowl twice, winning once.

Impact of the Investigation on the Colts and NFL Community

The FBI’s investigation into Jim Irsay’s death has sent ripples through the NFL community and the Colts organization. While the probe focuses on medical and legal aspects surrounding Irsay’s drug use and treatment, it also raises broader questions about addiction, medical oversight, and the pressures faced by high-profile sports executives.

The Colts have reiterated their commitment to cooperating with authorities and supporting efforts to uncover the truth. Fans and stakeholders await further updates as the investigation unfolds, hoping for clarity and resolution.

Conclusion

The FBI’s probe into Jim Irsay’s death highlights the complex interplay between prescription drug use, addiction treatment, and medical accountability. As investigators delve deeper into his relationship with Dr. Haroutunian and the medications prescribed, the sports world watches closely. Understanding the full circumstances of Irsay’s passing is crucial not only for justice but also for raising awareness about the challenges of addiction and medical care.

Stay informed on this developing story and other sports news by subscribing to our newsletter and following our updates. Your awareness can make a difference.